" class="no-js "lang="en-US"> Novo Holdings Archives - Medtech Alert
Sunday, May 26, 2024

Sort by:


Top Post

Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease

An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]

Novo Holdings Invests in US$105 Million Series C Funding of Alentis Therapeutics

Novo Holdings A/S, a leading international life sciences investor, today announced it has participated in […]

Novo Holdings Co-Leads EUR 6M Seed Financing in Asgard Therapeutics

Novo Holdings, a leading international life science investor, today announces that it has co-led the EUR […]

Novo Holdings Co-leads Hemab's US$ 55M Series A to Advance Next Generation Therapeutics for Bleeding and Thrombosis Disorders

Novo Holdings, a leading international life science investor, today announces that it has co-led alongside […]

Muna Therapeutics Launches with US$ 73M Series A to Advance Novel Small Molecule Therapeutics for Neurodegenerative Diseases

Muna Therapeutics (“Muna”), pioneering the development of first-in-class small molecule therapeutics for neurodegenerative diseases, today […]

Esco Lifesciences Closes a Record-Setting US$200M Series A Round Led by Vivo Capital and Novo Holdings

Esco Lifesciences (“Esco”, the “Company”) announced today the close of an over-subscribed US$200 million Series A and Crossover […]

Novo Holdings Leads Series C in Hummingbird

Novo Holdings today announced that it has led the oversubscribed US$125 million Series C financing in Hummingbird […]

Novo Holdings Participates in US$ 80 Million Series C Investment in Indonesia's Largest Health-tech Platform Halodoc

Novo Holdings today announced that it has joined the US$ 80 million Series C financing in Halodoc, […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more